Cuyue Tang

Cuyue Tang has over 30 years of work experience in various roles within the pharmaceutical and biotechnology industry. Their most recent position is as the Vice President of DMPK & Clin Pharm at Morphic Therapeutic since July 2022. Prior to that, they served as the Vice President of DMPK at Remix Therapeutics from January 2021 to July 2022. Cuyue also held roles at Epizyme as an Executive Director from August 2018 to January 2021 and as a Senior Director from March 2016 to August 2018. They were previously a Senior Director of DMPK at FORUM Pharmaceuticals from October 2015 to March 2016 and a Director of DMPK from November 2013 to October 2015. Cuyue also worked at EnVivo Pharmaceuticals as an Associate Director from December 2012 to November 2013 and as a Senior Principal Scientist from December 2011 to December 2012. Their early career included positions at Merck as a Senior Investigator from November 2004 to October 2011, a Research Fellow from April 2000 to November 2004, and a Senior Research Biochemist from May 1995 to April 2000. Cuyue's educational background includes a postdoctoral fellowship at the University of Washington from September 1991 to May 1995.

Cuyue Tang holds a Doctor of Philosophy (Ph.D.) degree in Toxicology from Tongji Medical University in Wuhan, China.